TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) Investor Investigation Concerning Possible Violations of Securities Laws Announced

  • If you purchased shares of Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Can Fite Biopharma Ltd
Security
NYSEMKT: CANF

Summary

April 07, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) shares over potential securities laws violations by Can Fite Biopharma Ltd and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) concerning whether a series of statements by Can Fite Biopharma Ltd regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On March 30, 2015, Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) (TASE:CFBI) announced that its Phase II/III psoriasis trial for the Company's drug candidate CF101 did not achieve its primary endpoint. On this news, the price of Can-Fites shares declined by over 60%.

Start Monitoring Your Investments